PL372468A1 - Pseudopolimorfy izostrukturalne 9-deokso-9a-aza-9a-metylo-9a-homoerytromycyny A - Google Patents

Pseudopolimorfy izostrukturalne 9-deokso-9a-aza-9a-metylo-9a-homoerytromycyny A

Info

Publication number
PL372468A1
PL372468A1 PL03372468A PL37246803A PL372468A1 PL 372468 A1 PL372468 A1 PL 372468A1 PL 03372468 A PL03372468 A PL 03372468A PL 37246803 A PL37246803 A PL 37246803A PL 372468 A1 PL372468 A1 PL 372468A1
Authority
PL
Poland
Prior art keywords
homoerythromycin
deoxo
aza
methyl
pseudopolymorph
Prior art date
Application number
PL03372468A
Other languages
English (en)
Inventor
Miljenko Dumic
Mladen Vinkovic
Marina Oresic
Ernest Mestrovic
Aleksandar Danilovski
Alojz Dumbovic
Zdravka Knezevic
Gorjana Lazarevski
Dominik Cincic
Darko Filic
Katica Lazaric
Dejan-Kresimir Bucar
Original Assignee
Pliva-Istrazivanje I Razvoj D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Istrazivanje I Razvoj D.O.O. filed Critical Pliva-Istrazivanje I Razvoj D.O.O.
Publication of PL372468A1 publication Critical patent/PL372468A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Finger-Pressure Massage (AREA)
  • Instructional Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
PL03372468A 2002-03-18 2003-03-18 Pseudopolimorfy izostrukturalne 9-deokso-9a-aza-9a-metylo-9a-homoerytromycyny A PL372468A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HR20020231A HRP20020231A2 (en) 2002-03-18 2002-03-18 ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US39361202P 2002-07-03 2002-07-03
US39470502P 2002-07-08 2002-07-08

Publications (1)

Publication Number Publication Date
PL372468A1 true PL372468A1 (pl) 2005-07-25

Family

ID=28045976

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03372468A PL372468A1 (pl) 2002-03-18 2003-03-18 Pseudopolimorfy izostrukturalne 9-deokso-9a-aza-9a-metylo-9a-homoerytromycyny A

Country Status (23)

Country Link
US (1) US7569549B2 (pl)
EP (2) EP1627883A1 (pl)
JP (1) JP2005529082A (pl)
KR (1) KR20050002872A (pl)
CN (1) CN1642966A (pl)
AT (1) ATE440104T1 (pl)
AU (1) AU2003215779A1 (pl)
BG (1) BG108874A (pl)
BR (1) BR0308644A (pl)
CA (1) CA2479211A1 (pl)
DE (1) DE60328872D1 (pl)
EA (1) EA200401217A1 (pl)
ES (1) ES2331733T3 (pl)
HR (2) HRP20020231A2 (pl)
IL (1) IL163836A0 (pl)
IS (1) IS7449A (pl)
MX (1) MXPA04009009A (pl)
NO (1) NO20044341L (pl)
NZ (1) NZ535477A (pl)
PL (1) PL372468A1 (pl)
RS (1) RS82504A (pl)
TN (1) TNSN04166A1 (pl)
WO (1) WO2003077830A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
EP1648473B1 (en) 2003-07-24 2009-01-28 PLIVA HRVATSKA d.o.o. Single dose fast dissolving azithromycin
EP1878432A1 (en) * 2003-07-24 2008-01-16 Pliva - Research and Development Ltd. Single dose fast dissolving azithromycin
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053651A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
RU2331410C2 (ru) * 2003-12-04 2008-08-20 Пфайзер Продактс Инк. Способ получения фармацевтических мультичастиц
JP2007513147A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
BRPI0417338A (pt) * 2003-12-04 2007-04-17 Pfizer Prod Inc formas de dosagem de azitromicina multiparticulada por processos a base de lìquido
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
WO1994026758A1 (en) 1993-05-19 1994-11-24 Pfizer Inc. Intermediate for azithromycin
HRP940251B1 (en) 1994-04-15 1998-12-31 Stjepan Mutak Process for the preparation of azithromycin dihydrochloride
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CN1205338A (zh) 1998-05-08 1999-01-20 刘万忠 阿奇霉素水溶性盐的合成新方法及其在医药上的用途
US6245903B1 (en) 1998-08-21 2001-06-12 Apotex, Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
US6365574B2 (en) * 1998-11-30 2002-04-02 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
US6703372B1 (en) * 1999-06-29 2004-03-09 Biochemie S.A. Macrolides
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
CA2396426A1 (en) 2000-01-04 2001-07-12 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
ES2260047T3 (es) * 2000-07-25 2006-11-01 Laboratorio Silanes, S.A. De C.V. Proceso de etapa unica para la preparacion de 7,16-deoxi-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihidroxi-6-etil-3,5,9,11,13,15-hexametilbiciclo(11.2.1)hexadeca-1(2)-en-ona y obtencion de una forma nueva de 9-deoxo-9a-metil-9a-homoeritromicina a.
AU2001280000A1 (en) 2000-08-23 2002-03-04 Jaweed Mukarram, Siddiqui Mohammed Process for preparation of anhydrous azithromycin
HU229488B1 (hu) * 2000-11-27 2014-01-28 Sandoz Ag Eljárás makrolid hidrátok elõállítására
KR100491183B1 (ko) 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
KR100431431B1 (ko) 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
DE60209704T2 (de) 2001-05-22 2006-11-16 Pfizer Products Inc., Groton Neue kristallforme von azithromycin
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
NZ532707A (en) 2001-12-21 2006-07-28 Pfizer Prod Inc Directly compressible formulations of azithromycin
NZ532063A (en) 2001-12-21 2006-03-31 Pfizer Prod Inc Methods for wet granulating azithromycin
MXPA04007427A (es) 2002-02-01 2004-10-11 Pfizer Prod Inc Formulaciones de azitromicina granuladas por via seca.
ITMI20021209A1 (it) 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza

Also Published As

Publication number Publication date
US20040014951A1 (en) 2004-01-22
WO2003077830A3 (en) 2004-05-13
NO20044341L (no) 2004-11-23
HRP20020231A2 (en) 2003-12-31
EP1485393B1 (en) 2009-08-19
JP2005529082A (ja) 2005-09-29
NZ535477A (en) 2006-11-30
AU2003215779A1 (en) 2003-09-29
RS82504A (sr) 2006-12-15
MXPA04009009A (es) 2005-06-17
TNSN04166A1 (en) 2007-03-12
KR20050002872A (ko) 2005-01-10
EP1627883A1 (en) 2006-02-22
CN1642966A (zh) 2005-07-20
EA200401217A1 (ru) 2005-02-24
CA2479211A1 (en) 2003-09-25
DE60328872D1 (en) 2009-10-01
US7569549B2 (en) 2009-08-04
HRP20040858A2 (en) 2005-06-30
EP1485393A2 (en) 2004-12-15
WO2003077830A2 (en) 2003-09-25
BR0308644A (pt) 2005-01-25
BG108874A (en) 2005-12-30
ATE440104T1 (de) 2009-09-15
IS7449A (is) 2004-09-16
IL163836A0 (en) 2005-12-18
ES2331733T3 (es) 2010-01-14

Similar Documents

Publication Publication Date Title
IL163836A0 (en) Isostructural pseudopolymorphs of 9-deoxo-9A-aza-9-a-methyl-9A-homoerythromycin a
BR0014274A (pt) Composições de intercalação de catodo, métodos de produção e baterias de lìtio recarregáveis contendo as mesmas
EP1457550A3 (en) Composition for removing residues from the microstructure of an object
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
CA2391659A1 (en) Crystal forms of azithromycin
EP3738591A3 (en) Novel antibacterial agents
AU2003301185A1 (en) Treatment of fabrics, fibers, or yarns
WO2001098331A3 (en) Glucagon-like peptide-1 analogs
NO2012012I2 (no) Pasireotide (som diaspartat salt). Det kjemiske navnet er cyclo[(4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L-phenylalanyl-)
WO2000057866A3 (en) Use of azalide antibiotics for the topical treatment or prevention of ocular infections
HK1056114A1 (zh) 血子板减少模仿剂
AU2001236606A1 (en) 3,4-dihydro-2h-benzo(1,4)oxazine inhibitors of factor xa
PL367263A1 (pl) Związki spiropirazolowe
WO2005122870A3 (en) Lung access device
CA2395204A1 (en) Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
WO2003030886A3 (en) Allylamides useful in the treatment of alzheimer's disease
WO2004082629A3 (en) Novel cyclosporins
AU7866701A (en) Antibacterial chiral 8-(substituted piperidino)-benzo (i, j) quinolizines, processes, compositions and methods of treatment
WO2006041631A3 (en) Novel cyclosporin alkynes and their utility as pharmaceutical agents
WO2001009122A3 (en) Serotonergic benzofurans
WO2008042497A3 (en) Benzoxazole and benzothiazole compounds useful as authentication compounds in polymer articles
TW200609228A (en) Substituted n-acyl-2-aminothiazoles
WO2002098924A3 (en) Compositions including fluorinated peroxides, methods of making, and the use thereof
AU2003301886A1 (en) Articles treated with aqueous dispersions of poly(urea/urethanes)
AU2003263978A1 (en) 2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)